PRODUCT DETAIL

Kanpiduo 8 mg/2,5 mg tablety

Code

2167F

MA number

58/0435/25-S

Product Form:

tbl 14x8 mg/2,5 mg (blis.PVC/PVDC/Al - kalend.bal.)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

MAH, country:

KRKA, d.d., Novo mesto, Slovenia

Therapeutic Class:

58 - HYPOTENSIVA

ATC:

C	CARDIOVASCULAR SYSTEM
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D	ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
C09DA	Angiotensin II receptor blockers (ARBs) and diuretics
C09DA06	Candesartan and diuretics

Shelf life:

Container:

blister PVC/PVDC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10b fixed combination application
MA issued:	22.12.2025
Validity:	22.12.2030
Pediatric contraindication:	Yes
SPC:	SPC_Kanpiduo 8mg2,5mg, 16mg2,5mg_12_2025.pdf
PIL:	PIL_Kanpiduo 8mg2,5mg, 16mg2,5mg_12_2025.pdf
Safety feature	Yes
Data update:	23.12.2025